Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint

Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), William N. William(The University of Texas MD Anderson Cancer Center), Valerie W. Rusch(Memorial Sloan Kettering Cancer Center), Katherine M.W. Pisters(The University of Texas MD Anderson Cancer Center), Neda Kalhor(The University of Texas MD Anderson Cancer Center), Apar Pataer(The University of Texas MD Anderson Cancer Center), William D. Travis(Memorial Sloan Kettering Cancer Center), Stephen G. Swisher(The University of Texas MD Anderson Cancer Center), Mark G. Kris(Memorial Sloan Kettering Cancer Center)
The Lancet Oncology
January 1, 2014
10.1016/s1470-2045(13)70334-6
Cited by 629Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis